Table 8.
The assessment of the influence of variables on mortality—a Cox proportional hazards regression, single model.
| p-Value | HR | 95%CI HR (Lower) | 95%CI HR (Upper) | ||
|---|---|---|---|---|---|
| Sex (n = 1056) | M | 0.283 | 0.75 | 0.45 | 1.27 |
| BMI (n = 775) |
18.5–24.9 | Ref. | |||
| <18.5 | 0.486 | 3.26 | 0.49 | 21.75 | |
| 25.0–29.9 | 0.151 | 1.60 | 0.70 | 3.66 | |
| ≥30 | 0.028 | 0.51 | 0.19 | 1.32 | |
| NRS (n = 1055) |
<3 | Ref. | |||
| ≥3 | 0.014 | 2.31 | 1.19 | 4.49 | |
| HF phenotype (n = 1056) | HFpEF | Ref. | |||
| HFmrEF | 0.000 | 4.69 | 2.02 | 10.91 | |
| HFrEF | 0.376 | 0.91 | 0.33 | 2.50 | |
| No information | 0.067 | 0.84 | 0.44 | 1.61 | |
| NYHA (n = 986) | 1 | Ref. | |||
| 2 | 0.988 | 0.00 | 0.00 | ||
| 3 | 0.991 | 0.18 | 0.04 | 0.76 | |
| 4 | 0.988 | 0.37 | 0.17 | 0.82 | |
| MI (n = 1056) | Yes | 0.343 | 1.30 | 0.75 | 2.26 |
| CKD (n = 1056) | Yes | 0.321 | 0.76 | 0.44 | 1.31 |
| Type of MI (n = 1056) | No | Ref. | |||
| STEMI | 0.451 | 1.72 | 0.28 | 10.46 | |
| NSTEMI | 0.849 | 1.18 | 0.62 | 2.23 | |
| No information | 0.990 | 1.25 | 0.17 | 9.16 | |
| HT (n = 1056) | Yes | 0.506 | 0.83 | 0.48 | 1.44 |
| DM (n = 1056) | Yes | 0.714 | 1.10 | 0.65 | 1.86 |
| CS (n = 1056) | Yes | 0.249 | 1.48 | 0.76 | 2.87 |
| LDL (n = 1001) | <55 mg/dL | Ref. | |||
| 55 to <70 mg/dL | 0.826 | 0.65 | 0.11 | 3.82 | |
| 70 to <100 mg/dL | 0.413 | 0.34 | 0.06 | 2.13 | |
| 100 to <116 mg/dL | 0.386 | 0.06 | 0.01 | 0.48 | |
| 116 to <190 mg/dL | 0.009 | 0.10 | 0.02 | 0.45 | |
| more than 190 mg/dL | 0.038 | 3.20 | 0.41 | 25.22 | |
| LDL (n = 1001) | ≥70 | 0.003 | 0.42 | 0.24 | 0.75 |
| TG (n = 1009) | <135 | Ref. | |||
| 135–200 | 0.656 | 1.90 | 0.89 | 4.05 | |
| >200 | 0.130 | 2.53 | 1.16 | 5.52 | |
| HDL (n = 1005) | <40 | Ref. | |||
| >40 | 0.110 | 0.58 | 0.30 | 1.13 | |
| Variables | |||||
| Age (n = 1056) | 0.000 | 1.05 | 1.02 | 1.07 | |
| BMI [kg/m2] (n = 775) | 0.048 | 0.94 | 0.89 | 1.00 | |
| Height [m] (n = 763) | 0.435 | 0.99 | 0.95 | 1.02 | |
| Body weight [kg] (n = 761) | 0.019 | 0.98 | 0.96 | 1.00 | |
| NT-proBNP [pg/mL] (n = 228) | 0.779 | 1.00 | 1.00 | 1.00 | |
| BNP [pg/mL] (n = 775) | 0.006 | 1.00 | 1.00 | 1.00 | |
| TG [mg/dL] (n = 1009) | 0.050 | 1.00 | 1.00 | 1.01 | |
| LDL [mg/dL] (n = 1001) | 0.002 | 0.98 | 0.97 | 0.99 | |
| HDL [mg/dL] (n = 1005) | 0.001 | 0.95 | 0.93 | 0.98 | |
| TC [mg/dL] (n = 1010) | 0.000 | 0.98 | 0.98 | 0.99 | |
| CRP [mg/L] (n = 1023) | 0.000 | 1.01 | 1.01 | 1.01 | |
| Albumin [g/dL] (n = 278) | 0.000 | 0.34 | 0.19 | 0.62 | |
| Transferrin [g/L] (n = 261) | 0.126 | 0.56 | 0.27 | 1.18 | |
| Lymphocytes [%] (n = 375) | 0.000 | 0.92 | 0.88 | 0.96 | |
| PCT [ng/mL] (n = 428) | 0.003 | 1.07 | 1.02 | 1.12 | |
Abbreviations: n, number of participants; M, males; HR, hazard ratio; CI, confidence interval; p, level of significance; BMI, body mass index; NRS, nutritional risk screening; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFmrEF, heart failure with mid-range ejection fraction; HFrEF, heart failure with reduced ejection fraction; NYHA, New York Heart Association classification; CKD, chronic kidney disease; MI, myocardial infarction; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; HT, arterial hypertension; DM, diabetes mellitus; CS, cerebral stroke; LDL, low-density lipoprotein; TG, triglycerides; HDL, high-density lipoprotein; NT-proBNP, N-terminal pro-B type natriuretic peptide; BNP, B-type natriuretic peptide; TC, total cholesterol; CRP, C-reactive protein; PCT, procalcitonin.